Shanghai - Delayed Quote CNY
Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS)
289.15
+4.15
+(1.46%)
At close: 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,822,717.80
5,822,717.80
561,870.73
703,281.56
796,731.82
Cost of Revenue
264,385.24
264,385.24
229,283.46
232,737.90
197,725.10
Gross Profit
5,558,332.57
5,558,332.57
332,587.27
470,543.66
599,006.72
Operating Expense
1,814,673.28
1,814,673.28
1,074,813.90
723,492.13
692,284.92
Operating Income
3,743,659.29
3,743,659.29
-742,226.63
-252,948.48
-93,278.20
Net Non Operating Interest Income Expense
162,213.64
162,213.64
-19,656.13
-21,962.61
-8,522.49
Pretax Income
3,978,153.63
3,978,153.63
-769,012.97
-289,073.76
-104,436.68
Tax Provision
270,649.07
270,649.07
11,485.91
-6,694.67
-4,445.38
Net Income Common Stockholders
3,707,504.56
3,707,504.56
-780,498.88
-282,379.09
-99,991.30
Basic EPS
9.25
--
-1.95
-0.78
-0.28
Diluted EPS
9.25
--
-1.95
-0.78
-0.28
Basic Average Shares
400,811.30
--
400,255.84
362,024.47
357,111.78
Diluted Average Shares
400,811.30
--
400,255.84
362,024.47
357,111.78
Total Operating Income as Reported
3,978,884.39
3,978,884.39
-769,376.46
-287,634.81
-101,461.88
Total Expenses
2,079,058.52
2,079,058.52
1,304,097.36
956,230.04
890,010.02
Net Income from Continuing & Discontinued Operation
3,707,504.56
3,707,504.56
-780,498.88
-282,379.09
-99,991.30
Normalized Income
3,716,919.74
3,716,919.74
-775,706.13
-270,003.45
-97,443.21
Interest Income
206,087.36
206,087.36
5,703.21
766.60
474.83
Interest Expense
42,523.20
42,523.20
24,678.82
22,480.88
8,692.10
Net Interest Income
162,213.64
162,213.64
-19,656.13
-21,962.61
-8,522.49
EBIT
4,020,676.83
4,020,676.83
-744,334.16
-266,592.88
-95,744.58
EBITDA
4,100,270.79
4,100,270.79
-679,611.67
-203,651.84
-42,608.34
Reconciled Cost of Revenue
264,385.24
264,385.24
229,283.46
232,737.90
197,725.10
Reconciled Depreciation
79,593.97
79,593.97
64,722.48
62,941.04
53,136.24
Net Income from Continuing Operation Net Minority Interest
3,707,504.56
3,707,504.56
-780,498.88
-282,379.09
-99,991.30
Total Unusual Items Excluding Goodwill
-10,102.49
-10,102.49
-6,390.34
-12,669.04
-2,661.37
Total Unusual Items
-10,102.49
-10,102.49
-6,390.34
-12,669.04
-2,661.37
Normalized EBITDA
4,110,373.29
4,110,373.29
-673,221.33
-190,982.79
-39,946.97
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-687.31
-687.31
-1,597.58
-293.40
-113.28
12/31/2021 - 1/6/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade